OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanisms of VPS35-mediated neurodegeneration in Parkinson's disease
Dorian Sargent, Darren J. Moore
International review of movement disorders (2021), pp. 221-244
Open Access | Times Cited: 14
Dorian Sargent, Darren J. Moore
International review of movement disorders (2021), pp. 221-244
Open Access | Times Cited: 14
Showing 14 citing articles:
Understanding the contributions of VPS35 and the retromer in neurodegenerative disease
Erin T. Williams, Xi Chen, P. Anthony Otero, et al.
Neurobiology of Disease (2022) Vol. 170, pp. 105768-105768
Open Access | Times Cited: 33
Erin T. Williams, Xi Chen, P. Anthony Otero, et al.
Neurobiology of Disease (2022) Vol. 170, pp. 105768-105768
Open Access | Times Cited: 33
VPS35 and retromer dysfunction in Parkinson's disease
Jordan Rowlands, Darren J. Moore
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 6
Jordan Rowlands, Darren J. Moore
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 6
Novel variants in genes related to vesicle-mediated-transport modify Parkinson's disease risk
Orly Goldstein, Mali Gana‐Weisz, Sandro Banfi, et al.
Molecular Genetics and Metabolism (2023) Vol. 139, Iss. 2, pp. 107608-107608
Closed Access | Times Cited: 5
Orly Goldstein, Mali Gana‐Weisz, Sandro Banfi, et al.
Molecular Genetics and Metabolism (2023) Vol. 139, Iss. 2, pp. 107608-107608
Closed Access | Times Cited: 5
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson’s disease
Xi Chen, Elpida Tsika, Nathan Levine, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Xi Chen, Elpida Tsika, Nathan Levine, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Exploring the interplay between metabolomics and genetics in Parkinson's disease: Insights from ongoing research and future avenues
Cíntia Barros Santos-Rebouças, Juliana Cordovil Cotrin, Gilson Costa dos Santos
Mechanisms of Ageing and Development (2023) Vol. 216, pp. 111875-111875
Closed Access | Times Cited: 5
Cíntia Barros Santos-Rebouças, Juliana Cordovil Cotrin, Gilson Costa dos Santos
Mechanisms of Ageing and Development (2023) Vol. 216, pp. 111875-111875
Closed Access | Times Cited: 5
Intermittent hypoxia training enhances Aβ endocytosis by plaque associated microglia via VPS35-dependent TREM2 recycling in murine Alzheimer’s disease
Xueting Wang, Yuqi Xie, Xiaoyang Fan, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Xueting Wang, Yuqi Xie, Xiaoyang Fan, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
VPS35 or retromer as a potential target for neurodegenerative disorders: barriers to progress
Anika Wu, Daehoon Lee, Wen-Cheng Xiong
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 8, pp. 701-712
Open Access | Times Cited: 1
Anika Wu, Daehoon Lee, Wen-Cheng Xiong
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 8, pp. 701-712
Open Access | Times Cited: 1
The crucial role of VPS35 and SHH in Parkinson’s disease: Understanding the mechanisms behind the neurodegenerative disorder
Kritika Bhardwaj, Akanksha Jha, Abhishek Roy, et al.
Brain Research (2024) Vol. 1845, pp. 149204-149204
Closed Access | Times Cited: 1
Kritika Bhardwaj, Akanksha Jha, Abhishek Roy, et al.
Brain Research (2024) Vol. 1845, pp. 149204-149204
Closed Access | Times Cited: 1
Developmental pathways linked to the vulnerability of adult midbrain dopaminergic neurons to neurodegeneration
Nilima Prakash
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 5
Nilima Prakash
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 5
Unveiling Neuroprotection and Regeneration Mechanisms in Optic Nerve Injury: Insight from Neural Progenitor Cell Therapy with Focus on Vps35 and Syntaxin12
Hyun-Ah Shin, Mira Park, Hey Jin Lee, et al.
(2023)
Open Access | Times Cited: 1
Hyun-Ah Shin, Mira Park, Hey Jin Lee, et al.
(2023)
Open Access | Times Cited: 1
Unveiling Neuroprotection and Regeneration Mechanisms in Optic Nerve Injury: Insight from Neural Progenitor Cell Therapy with Focus on Vps35 and Syntaxin12
Hyun-Ah Shin, Mira Park, Hey Jin Lee, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2412-2412
Open Access | Times Cited: 1
Hyun-Ah Shin, Mira Park, Hey Jin Lee, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2412-2412
Open Access | Times Cited: 1
Exploring the triad: VPS35 , neurogenesis, and neurodegenerative diseases
Zixiong Qiu, Xuliang Deng, Yuan Fu, et al.
Journal of Neurochemistry (2024)
Closed Access
Zixiong Qiu, Xuliang Deng, Yuan Fu, et al.
Journal of Neurochemistry (2024)
Closed Access
Unravelling Parkinson’s Disease Therapeutics: Computational Insights into VPS35 via Drug Repurposing
Anjali Roy, Pravir Kumar
(2024), pp. 1-5
Closed Access
Anjali Roy, Pravir Kumar
(2024), pp. 1-5
Closed Access
Molecular Mechanisms of Degeneration in Parkinson’s Disease; Deep Brain Stimulation, Pluripotent Stem Cell Therapy, and Cutting Edge Technology in Treatment Of Parkinson’s Disease
Siddharth Shah, Abiy Tereda, Hadeel M. Mansour
Current Genetic Medicine Reports (2024)
Closed Access
Siddharth Shah, Abiy Tereda, Hadeel M. Mansour
Current Genetic Medicine Reports (2024)
Closed Access
